Who buys medicines through tenders?
Four kinds of buyer run most medicine tenders in Europe. Individual hospitals and hospital groups buy for their own pharmacies. Purchasing groups and regional central bodies pool the demand of many hospitals. National bodies buy for a whole health system in countries such as Denmark, Norway, Portugal and Greece. In Germany and the Netherlands, health insurers decide which outpatient generic pharmacies dispense.
The type of buyer decides the size of the prize. A single insurer or national round can settle a molecule's volume for years, while a hospital tender may cover a few thousand packs.
Hospital tenders and outpatient tenders are different markets
Almost every European country tenders hospital medicines. Far fewer tender the generics that patients collect at a pharmacy. Germany (insurer discount contracts), the Netherlands (insurer preference policy) and the Nordic countries tender outpatient generics at scale; most other countries set outpatient prices through reimbursement rules instead.
How a tender is structured
- Lots: each lot is awarded separately, usually one molecule, strength or presentation, sometimes one region.
- Award criteria: lowest price, or the most economically advantageous tender (price plus quality, service, supply security or environmental criteria).
- Number of winners: one supplier per lot, or two to three ranked or shared partners.
- Contract form: a framework agreement of up to four years under EU rules, with orders placed during the term.
- Volumes: usually estimated or maximum quantities, rarely a commitment.
What bidders see after the award
Buyers publish an award notice naming the winner per lot, and many publish the price. Some publish every bidder's offer; others give only a total contract value, and some prices, such as German insurer discounts, are never published. Reading results across countries therefore means knowing what each buyer publishes and what it never does.
What is changing
Buyers are moving from price-only awards towards criteria on supply security, multiple suppliers per lot and, in France since August 2026, a mandatory environmental criterion. The EU Critical Medicines Act, agreed provisionally in 2026 but not yet in force, would push further in the same direction for medicines judged critical.
Questions
Which European countries tender outpatient generics?
Germany through insurer discount contracts, the Netherlands through insurer preference policy, and the Nordic countries through national or regional tenders. Most other countries tender only hospital medicines and set pharmacy prices through reimbursement rules.
Are pharmaceutical tenders in Europe winner-takes-all?
Not always. Many buyers still award each lot to one supplier, but more and more award two or three partners per lot, or rank several suppliers in a framework, to reduce the risk of shortages.
How long do medicine tender contracts last?
Usually one to four years. EU rules limit framework agreements to four years in most cases, and many insurer and hospital contracts run for about two years, sometimes with extension options.